For announcements related to COVID-19, please visit our COVID-19 Updates. Please visit the Research Staff Resources section to stay informed on COVID-19 recommendations specific to research.
1 - 10 of 54
The FDA issued guidance in light of the challenges to the conduct of clinical trials of medical products during the COVID-19 crisis.
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
Guidance on approval process for in-person contact with study subjects or biospecimens during the COVID-19 Pandemic.
The Arcus Education team’s calendar of events is expanding, with daily offerings to enhance your computational and quantitative skills.
Introducing virtual office hours with Academic Training and Outreach Programs: Sign up for a 30-minute career chat with an ATOP adviser.
Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
Options to ship study drugs during COVID-19
Important frequently asked research questions related to clinical trials and non-interventional clinical research.
Discontinue all nonessential on-campus research activities on or before March 17 in response to COVID-19 pandemic.
Review this guidance to ensure successful suspension/reduction of your laboratory operations.